|
GS185131: GO:0044699 single-organism process
|
|
GS192574: GO:0051430 corticotropin-releasing hormone receptor 1 binding
|
|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS205510: GO:0001883 purine nucleoside binding
|
|
GS128223: Proteins found to be modified by at least two drugs of abuse
|
|
GS136137: lithogenic gene 18 (Lith18, Published QTL Chr 8)
|
|
GS169076: MP:0002079 increased circulating insulin level
|
|
GS121514: Paraquat interacting genes (MeSH:D010269) in CTD
|
|
GS170691: MP:0002693 abnormal pancreas physiology
|
|
GS199701: GO:0003924 GTPase activity
|
|
GS135547: CD4 T cell subset 3 (Cd4ts3, Published QTL Chr 8)
|
|
GS184984: GO:0032553 ribonucleotide binding
|
|
GS190247: GO:0032403 protein complex binding
|
|
GS183645: GO:0017076 purine nucleotide binding
|
|
GS165257: MP:0001396 unidirectional circling
|
|
GS135948: HDL QTL 16 (Hdlq16, Published QTL Chr 8)
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS191088: GO:0009199 ribonucleoside triphosphate metabolic process
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS165643: MP:0011088 partial neonatal lethality
|
|
GS168070: MP:0002626 increased heart rate
|
|
GS136657: skeletal muscle weight 16 (Skmw16, Published QTL Chr 8)
|
|
GS204630: GO:1901565 organonitrogen compound catabolic process
|
|
GS198309: GO:0007212 dopamine receptor signaling pathway
|
|
GS170568: MP:0003998 decreased thermal nociceptive threshold
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS196343: GO:0036094 small molecule binding
|
|
GS186215: GO:0048519 negative regulation of biological process
|
|
GS210137: GO:0016462 pyrophosphatase activity
|
|
GS201251: GO:0044424 intracellular part
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS170024: MP:0011086 partial postnatal lethality
|
|
GS201686: GO:0031852 mu-type opioid receptor binding
|
|
GS192508: GO:0006811 ion transport
|
|
GS126466: Quercetin interacting genes (MeSH:D011794) in CTD
|
|
GS183543: GO:0051179 localization
|
|
GS178909: GO:0017111 nucleoside-triphosphatase activity
|
|
GS166708: MP:0002164 abnormal gland physiology
|
|
GS188701: GO:0003015 heart process
|
|
GS177303: GO:0051428 peptide hormone receptor binding
|
|
GS205500: GO:0071944 cell periphery
|
|
GS209108: GO:0000166 nucleotide binding
|
|
GS135482: bone response to mechanical loading 2 (Brml2, Published QTL Chr 8)
|
|
GS163824: MP:0001259 abnormal body weight
|
|
GS181721: GO:0006163 purine nucleotide metabolic process
|
|
GS191408: GO:0051924 regulation of calcium ion transport
|
|
GS188652: GO:0001882 nucleoside binding
|
|
GS183388: GO:1900542 regulation of purine nucleotide metabolic process
|
|
GS204106: GO:0060089 molecular transducer activity
|
|
GS204645: GO:0043547 positive regulation of GTPase activity
|
|
GS205659: GO:0042493 response to drug
|
|
GS205653: GO:0070838 divalent metal ion transport
|
|
GS184456: GO:0009894 regulation of catabolic process
|
|
GS206616: GO:0007187 G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
|
|
GS199897: GO:0043279 response to alkaloid
|
|
GS203266: GO:0006140 regulation of nucleotide metabolic process
|
|
GS201799: GO:0032550 purine ribonucleoside binding
|
|
GS182900: GO:0003924 GTPase activity
|
|
GS189743: GO:0007186 G-protein coupled receptor signaling pathway
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS127931: Olfactory bulb - Allen Mouse Brain Atlas
|
|
GS166047: MP:0009114 decreased pancreatic beta cell mass
|
|
GS178426: GO:0005102 receptor binding
|
|
GS170733: MP:0000188 abnormal circulating glucose level
|
|
GS189106: GO:0008015 blood circulation
|
|
GS186333: GO:0033124 regulation of GTP catabolic process
|
|
GS199854: GO:0019001 guanyl nucleotide binding
|
|
GS1139: Differential expression response 4 hr after 2g/kg EtOH in C57BL/6J and DBA/2J
|
|
GS188792: GO:0070838 divalent metal ion transport
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS178401: GO:0019637 organophosphate metabolic process
|
|
GS178913: GO:0042221 response to chemical stimulus
|
|
GS198782: GO:0044459 plasma membrane part
|
|
GS128597: Ethanol Induced Ataxia Chr#8
|
|
GS182835: GO:0005622 intracellular
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS189224: GO:0007610 behavior
|
|
GS164468: MP:0001560 abnormal circulating insulin level
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS135540: cerebellum weight 2 (Cbm2, Published QTL Chr 8)
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS169075: MP:0002078 abnormal glucose homeostasis
|
|
GS207389: GO:0009150 purine ribonucleotide metabolic process
|
|
GS127934: Retrohippocampal region - Allen Mouse Brain Atlas
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS208187: GO:0010033 response to organic substance
|
|
GS800: UCSD_CEREBELLUM_Additive_Time_Pattern_4th
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS87284: Table S8: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT OF DELTACJUN (Whole Table) [DRG]
provisional
|
|
GS184448: GO:0044425 membrane part
|
|
GS191196: GO:0031234 extrinsic to internal side of plasma membrane
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS200341: GO:0051179 localization
|
|
GS206742: GO:0043167 ion binding
|
|
GS202828: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS184463: GO:0009898 internal side of plasma membrane
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS205560: GO:0003015 heart process
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS87259: Table 2: Mean p-value and z-ratio scores for 65 selected transcripts (Whole Table) [DRG]
provisional
|
|
GS135972: wound healing/regeneration 1 (Heal1, Published QTL Chr 8)
|
|
GS86424: Table S6: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT AT 1, 2 AND 4 WEEKS [DRG]
provisional
|
|
GS181473: GO:0005488 binding
|
|
GS197801: GO:0007420 brain development
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS180644: GO:0032549 ribonucleoside binding
|
|
GS87150: Table S6: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT AT 1, 2 AND 4 WEEKS [DRG]
provisional
|
|
GS186328: GO:0033121 regulation of purine nucleotide catabolic process
|
|
GS207616: GO:0016020 membrane
|
|
GS182665: GO:0042278 purine nucleoside metabolic process
|
|
GS198004: GO:0007399 nervous system development
|
|
GS164264: MP:0002082 postnatal lethality
|
|
GS203058: GO:0048519 negative regulation of biological process
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS169009: MP:0001629 abnormal heart rate
|
|
GS128577: Ethanol induced LORR Chr# 8
|
|
GS135886: forelimb polydactyly (Fpdty, Published QTL Chr 8)
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS209199: GO:0007165 signal transduction
|
|
GS163138: MP:0005253 abnormal eye physiology
|
|
GS188962: GO:1901292 nucleoside phosphate catabolic process
|
|
GS127938: Striatum - Allen Mouse Brain Atlas
|
|
GS194482: GO:0019898 extrinsic to membrane
|
|
GS202895: GO:0030811 regulation of nucleotide catabolic process
|
|
GS206737: GO:0043168 anion binding
|
|
GS183592: GO:0032561 guanyl ribonucleotide binding
|
|
GS170774: MP:0003562 abnormal pancreatic beta cell physiology
|
|
GS199986: GO:0009719 response to endogenous stimulus
|
|
GS35085: Neocortex Gene expression correlates of Mean time on rotarod during training. in Females & Males BXD
|
|
GS169032: MP:0005551 abnormal eye electrophysiology
|
|
GS191700: GO:0006753 nucleoside phosphate metabolic process
|
|
GS205558: GO:0003013 circulatory system process
|
|
GS187451: GO:0007568 aging
|
|
GS208012: GO:0044464 cell part
|
|
GS201252: GO:0044425 membrane part
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS197630: GO:0001664 G-protein coupled receptor binding
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS192511: GO:0006816 calcium ion transport
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS205825: GO:1901292 nucleoside phosphate catabolic process
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS135589: P. chabaudi malaria resistance QTL 2 (Char2, Published QTL Chr 8)
|
|
GS167371: MP:0010147 abnormal endocrine pancreas physiology
|
|
GS205144: GO:0048468 cell development
|
|
GS125445: Phenobarbital interacting genes (MeSH:D010634) in CTD
|
|
GS204027: GO:0044708 single-organism behavior
|
|
GS209041: GO:0043087 regulation of GTPase activity
|
|
GS196432: GO:0030001 metal ion transport
|
|
GS190492: GO:0009154 purine ribonucleotide catabolic process
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS201019: GO:0046039 GTP metabolic process
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS186421: GO:0006140 regulation of nucleotide metabolic process
|
|
GS185236: GO:0006184 GTP catabolic process
|
|
GS168021: MP:0000745 tremors
|
|
GS196002: GO:0048699 generation of neurons
|
|
GS127928: Lateral septal complex - Allen Mouse Brain Atlas
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS199635: GO:0005622 intracellular
|
|
GS193527: GO:1901068 guanosine-containing compound metabolic process
|
|
GS200273: GO:0014072 response to isoquinoline alkaloid
|
|
GS194304: GO:0009164 nucleoside catabolic process
|
|
GS169227: MP:0001405 impaired coordination
|
|
GS127935: Striatum dorsal region - Allen Mouse Brain Atlas
|
|
GS196912: GO:0046128 purine ribonucleoside metabolic process
|
|
GS186758: GO:0034655 nucleobase-containing compound catabolic process
|
|
GS35301: Striatum Gene expression correlates of Acoustic Startle Response Percentage of maximum startle response at 70 db in Females & Males BXD
|
|
GS36750: Hippocampus Gene expression correlates of Vocalization Threshold - shock intensity (mA) in Females & Males BXD
|
|
GS193233: GO:0031329 regulation of cellular catabolic process
|
|
GS86596: Table S6: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT AT 1, 2 AND 4 WEEKS [DRG]
provisional
|
|
GS165244: MP:0010771 integument phenotype
|
|
GS205437: GO:0000302 response to reactive oxygen species
|
|
GS208185: GO:0010035 response to inorganic substance
|
|
GS196941: GO:0008150 biological_process
|
|
GS35824: Neocortex Gene expression correlates of Cocaine CPP - Time (s) in saline paired compartment a in Males BXD
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS164854: MP:0001360 abnormal social investigation
|
|
GS205522: GO:0043269 regulation of ion transport
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS206031: GO:0072511 divalent inorganic cation transport
|
|
GS201431: GO:0005515 protein binding
|
|
GS188663: GO:0043269 regulation of ion transport
|
|
GS136390: autoimmune orchitis resistance 6 (Orch6, Published QTL Chr 8)
|
|
GS187247: GO:0060089 molecular transducer activity
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS180838: GO:0001664 G-protein coupled receptor binding
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS199267: GO:0043234 protein complex
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS826: UCSD_CEREBELLUM_Interaction_Reduced_Age_4th
|
|
GS194504: GO:1901136 carbohydrate derivative catabolic process
|
|
GS202323: GO:0007626 locomotory behavior
|
|
GS204095: GO:0030182 neuron differentiation
|
|
GS190496: GO:0009150 purine ribonucleotide metabolic process
|
|
GS202941: GO:0006936 muscle contraction
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS184629: GO:0005515 protein binding
|
|
GS208636: GO:0006753 nucleoside phosphate metabolic process
|
|
GS189767: GO:0031821 G-protein coupled serotonin receptor binding
|
|
GS168931: MP:0001431 abnormal eating behavior
|
|
GS169967: MP:0001408 stereotypic behavior
|
|
GS203328: GO:0007188 adenylate cyclase-modulating G-protein coupled receptor signaling pathway
|
|
GS185991: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS202760: GO:0004871 signal transducer activity
|
|
GS194041: GO:1901361 organic cyclic compound catabolic process
|
|
GS163569: MP:0002557 abnormal social/conspecific interaction
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS192461: GO:0046130 purine ribonucleoside catabolic process
|
|
GS201002: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS182175: GO:0006152 purine nucleoside catabolic process
|
|
GS170245: MP:0004022 abnormal cone electrophysiology
|
|
GS184214: GO:0046039 GTP metabolic process
|
|
GS196806: GO:0032502 developmental process
|
|
GS187633: GO:0019693 ribose phosphate metabolic process
|
|
GS122603: Pentobarbital interacting genes (MeSH:D010424) in CTD
|
|
GS170044: MP:0008874 decreased physiological sensitivity to xenobiotic
|
|
GS203082: GO:0009143 nucleoside triphosphate catabolic process
|
|
GS193491: GO:0072523 purine-containing compound catabolic process
|
|
GS169396: MP:0002069 abnormal eating/drinking behavior
|
|
GS181988: GO:0044459 plasma membrane part
|
|
GS184198: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS164230: MP:0005217 abnormal pancreatic beta cell morphology
|
|
GS200182: GO:1900542 regulation of purine nucleotide metabolic process
|
|
GS194505: GO:1901135 carbohydrate derivative metabolic process
|
|
GS135513: "body weight, QTL 3" (Bwq3, Published QTL Chr 8)
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS127925: Hippocampal formation - Allen Mouse Brain Atlas
|
|
GS208810: GO:0009259 ribonucleotide metabolic process
|
|
GS177356: GO:0003674 molecular_function
|
|
GS163227: MP:0003313 abnormal locomotor activation
|
|
GS195069: GO:0030900 forebrain development
|
|
GS207143: GO:0032403 protein complex binding
|
|
GS188247: GO:0051427 hormone receptor binding
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS136533: preaxial shift (Prxsh, Published QTL Chr 8)
|
|
GS202057: GO:0006184 GTP catabolic process
|
|
GS201504: GO:0034097 response to cytokine stimulus
|
|
GS136313: non-HDL QTL 1 (Nhdlq1, Published QTL Chr 8)
|
|
GS206091: GO:0007610 behavior
|
|
GS183398: GO:0005834 heterotrimeric G-protein complex
|
|
GS196181: GO:0031628 opioid receptor binding
|
|
GS135989: Hfe modifier 2 (Hfem2, Published QTL Chr 8)
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS127937: Striatum-like amygdalar nuclei - Allen Mouse Brain Atlas
|
|
GS164046: MP:0001968 abnormal touch/ nociception
|
|
GS164399: MP:0003058 increased insulin secretion
|
|
GS166070: MP:0008873 increased physiological sensitivity to xenobiotic
|
|
GS187193: GO:0044057 regulation of system process
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS136068: immune response to AAV2 QTL 2 (Imraq2, Published QTL Chr 8)
|
|
GS168956: MP:0003491 abnormal voluntary movement
|
|
GS185961: GO:0051049 regulation of transport
|
|
GS186237: GO:0009143 nucleoside triphosphate catabolic process
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS201794: GO:0032555 purine ribonucleotide binding
|
|
GS208110: GO:0031234 extrinsic to internal side of plasma membrane
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS187023: GO:1901265 nucleoside phosphate binding
|
|
GS136920: vertebral morphology and mechanical traits 8 (Vmmt8, Published QTL Chr 8)
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS35271: Striatum Gene expression correlates of Maximum startle response to 85 db in Females BXD
|
|
GS191870: GO:0009259 ribonucleotide metabolic process
|
|
GS188308: GO:0010243 response to organic nitrogen
|
|
GS195977: GO:0007154 cell communication
|
|
GS204496: GO:0019693 ribose phosphate metabolic process
|
|
GS169393: MP:0002064 seizures
|
|
GS180120: GO:0009205 purine ribonucleoside triphosphate metabolic process
|
|
GS205691: GO:0022008 neurogenesis
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS182469: GO:0043234 protein complex
|
|
GS136369: obesity QTL 16 (Obq16, Published QTL Chr 8)
|
|
GS200275: GO:0014070 response to organic cyclic compound
|
|
GS180164: GO:0008150 biological_process
|
|
GS205972: GO:0008015 blood circulation
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS207293: GO:0032879 regulation of localization
|
|
GS185921: GO:0004871 signal transducer activity
|
|
GS136733: susceptibility to lung cancer 9 (Sluc9, Published QTL Chr 8)
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS127930: Midbrain - Allen Mouse Brain Atlas
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS190954: GO:0009056 catabolic process
|
|
GS202822: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS203177: GO:0033124 regulation of GTP catabolic process
|
|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS165764: MP:0004085 abnormal heartbeat
|
|
GS167914: MP:0000951 sporadic seizures
|
|
GS124648: Lipopolysaccharides interacting genes (MeSH:D008070) in CTD
|
|
GS201949: GO:0044699 single-organism process
|
|
GS190397: GO:0032879 regulation of localization
|
|
GS187749: GO:0019220 regulation of phosphate metabolic process
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS188641: GO:0071944 cell periphery
|
|
GS190177: GO:0051051 negative regulation of transport
|
|
GS181223: GO:0046434 organophosphate catabolic process
|
|
GS178461: GO:0009987 cellular process
|
|
GS166380: MP:0008872 abnormal physiological response to xenobiotic
|
|
GS200393: GO:0032561 guanyl ribonucleotide binding
|
|
GS208912: GO:0046700 heterocycle catabolic process
|
|
GS192041: GO:0043169 cation binding
|
|
GS35306: Striatum Gene expression correlates of Acoustic Startle Response Percentage of maximum startle response at 80 db in Females & Males BXD
|
|
GS210507: GO:0006950 response to stress
|
|
GS186240: GO:0009146 purine nucleoside triphosphate catabolic process
|
|
GS197054: GO:0006195 purine nucleotide catabolic process
|
|
GS165253: MP:0001399 hyperactivity
|
|
GS167941: MP:0001970 abnormal pain threshold
|
|
GS836: Differential expression in Sey Pax6 mutants and controls. Additive effect of mutation, linear increase in both mutants and Wild-types.
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS35281: Striatum Gene expression correlates of Prepulse inhibition at 70db in Females & Males BXD
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS127923: Cerebellum - Allen Mouse Brain Atlas
|
|
GS209215: GO:0007166 cell surface receptor signaling pathway
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS135840: femoral bone trait QTL 3 (Fbtq3, Published QTL Chr 8)
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS197443: GO:0032549 ribonucleoside binding
|
|
GS202188: GO:0044248 cellular catabolic process
|
|
GS180134: GO:0046128 purine ribonucleoside metabolic process
|
|
GS192279: GO:0007166 cell surface receptor signaling pathway
|
|
GS170583: MP:0005407 hyperalgesia
|
|
GS205165: GO:0010243 response to organic nitrogen
|
|
GS189350: GO:0042454 ribonucleoside catabolic process
|
|
GS192672: GO:0055086 nucleobase-containing small molecule metabolic process
|
|
GS165528: MP:0005379 endocrine/exocrine gland phenotype
|
|
GS169835: MP:0005389 reproductive system phenotype
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS180122: GO:0009203 ribonucleoside triphosphate catabolic process
|
|
GS136061: immunoregulatory 3 (Im3, Published QTL Chr 8)
|
|
GS180276: GO:0006195 purine nucleotide catabolic process
|
|
GS191106: GO:0044464 cell part
|
|
GS182755: GO:0071855 neuropeptide receptor binding
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS209401: GO:0046130 purine ribonucleoside catabolic process
|
|
GS198972: GO:0006152 purine nucleoside catabolic process
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS196894: GO:0009207 purine ribonucleoside triphosphate catabolic process
|
|
GS177311: GO:1901361 organic cyclic compound catabolic process
|
|
GS177737: GO:0019897 extrinsic to plasma membrane
|
|
GS167025: MP:0003953 abnormal hormone level
|
|
GS178803: GO:0051336 regulation of hydrolase activity
|
|
GS199417: GO:1901069 guanosine-containing compound catabolic process
|
|
GS168579: MP:0003635 abnormal synaptic transmission
|
|
GS35075: Neocortex Gene expression correlates of Mean time on rotarod following saline in Females & Males BXD
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS180118: GO:0009207 purine ribonucleoside triphosphate catabolic process
|
|
GS203608: GO:0034655 nucleobase-containing compound catabolic process
|
|
GS177565: GO:0009166 nucleotide catabolic process
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS204315: GO:0007568 aging
|
|
GS135883: femur geometry 7 (Fmgty7, Published QTL Chr 8)
|
|
GS177567: GO:0009164 nucleoside catabolic process
|
|
GS206726: GO:0009261 ribonucleotide catabolic process
|
|
GS168502: MP:0002058 neonatal lethality
|
|
GS208978: GO:0043169 cation binding
|
|
GS201800: GO:0032553 ribonucleotide binding
|
|
GS35286: Striatum Gene expression correlates of Prepulse inhibition at 80db in Females & Males BXD
|
|
GS189748: GO:0050790 regulation of catalytic activity
|
|
GS189165: GO:0072511 divalent inorganic cation transport
|
|
GS188651: GO:0001883 purine nucleoside binding
|
|
GS36086: Cerebellum Gene expression correlates of Activity in altered context in fear conditioning apparatus in Females BXD
|
|
GS136572: radiation induced acute myeloid leukemia 4 (Raml4, Published QTL Chr 8)
|
|
GS189484: GO:0023052 signaling
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS207070: GO:0051051 negative regulation of transport
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS208021: GO:0051345 positive regulation of hydrolase activity
|
|
GS207995: GO:0009199 ribonucleoside triphosphate metabolic process
|
|
GS209454: GO:0006816 calcium ion transport
|
|
GS177743: GO:0019898 extrinsic to membrane
|
|
GS210177: GO:0031329 regulation of cellular catabolic process
|
|
GS136356: novelty/stress induced locomotor activation 7 (Nsila7, Published QTL Chr 8)
|
|
GS167651: MP:0001944 abnormal pancreas morphology
|
|
GS189860: GO:0043167 ion binding
|
|
GS204054: GO:0044057 regulation of system process
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS206781: GO:0009116 nucleoside metabolic process
|
|
GS165386: MP:0001262 decreased body weight
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS135259: autoimmune extremity vasculitis in MRL mice 1 (Aevm1, Published QTL Chr 8)
|
|
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
|
|
GS169390: MP:0002067 abnormal sensory capabilities/reflexes/nociception
|
|
GS182699: GO:0051174 regulation of phosphorus metabolic process
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS188699: GO:0003013 circulatory system process
|
|
GS194302: GO:0009166 nucleotide catabolic process
|
|
GS186238: GO:0009144 purine nucleoside triphosphate metabolic process
|
|
GS208331: GO:0051926 negative regulation of calcium ion transport
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS189896: GO:0009117 nucleotide metabolic process
|
|
GS181666: GO:0019439 aromatic compound catabolic process
|
|
GS204610: GO:0019220 regulation of phosphate metabolic process
|
|
GS193991: GO:0048731 system development
|
|
GS164228: MP:0005215 abnormal pancreatic islet morphology
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS124711: Genistein interacting genes (MeSH:D019833) in CTD
|
|
GS165726: MP:0002733 abnormal thermal nociception
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS193018: GO:0003008 system process
|
|
GS199459: GO:0042278 purine nucleoside metabolic process
|
|
GS203173: GO:0033121 regulation of purine nucleotide catabolic process
|
|
GS184447: GO:0044424 intracellular part
|
|
GS189897: GO:0009116 nucleoside metabolic process
|
|
GS207862: GO:0009056 catabolic process
|
|
GS198455: GO:0019439 aromatic compound catabolic process
|
|
GS170768: MP:0003564 abnormal insulin secretion
|
|
GS193489: GO:0072521 purine-containing compound metabolic process
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS210435: GO:0072521 purine-containing compound metabolic process
|
|
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS210437: GO:0072523 purine-containing compound catabolic process
|
|
GS203335: GO:0048513 organ development
|
|
GS198012: GO:0046434 organophosphate catabolic process
|
|
GS136300: mean platelet volume locus 2 (Mpvq2, Published QTL Chr 8)
|
|
GS166712: MP:0002161 abnormal fertility/fecundity
|
|
GS183188: GO:0009719 response to endogenous stimulus
|
|
GS179671: GO:0030001 metal ion transport
|
|
GS206052: GO:0031683 G-protein beta/gamma-subunit complex binding
|
|
GS136131: lithogenic gene 11 (Lith11, Published QTL Chr 8)
|
|
GS210212: GO:0005575 cellular_component
|
|
GS170685: MP:0002694 abnormal pancreas secretion
|
|
GS135466: blood pressure QTL 23 (Bpq23, Published QTL Chr 8)
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS209451: GO:0006811 ion transport
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS166041: MP:0009112 abnormal pancreatic beta cell mass
|
|
GS179580: GO:0036094 small molecule binding
|
|
GS204692: GO:0060047 heart contraction
|
|
GS210472: GO:1901068 guanosine-containing compound metabolic process
|
|
GS190899: GO:0043005 neuron projection
|
|
GS168088: MP:0011110 partial preweaning lethality
|
|
GS181519: GO:0007212 dopamine receptor signaling pathway
|
|
GS189194: GO:0010959 regulation of metal ion transport
|
|
GS184874: GO:0031852 mu-type opioid receptor binding
|
|
GS196896: GO:0009205 purine ribonucleoside triphosphate metabolic process
|
|
GS206615: GO:0007186 G-protein coupled receptor signaling pathway
|
|
GS164263: MP:0002083 premature death
|
|
GS210376: GO:0007417 central nervous system development
|
|
GS201267: GO:0009898 internal side of plasma membrane
|
|
GS195905: GO:0008016 regulation of heart contraction
|
|
GS182834: GO:0005623 cell
|
|
GS205511: GO:0001882 nucleoside binding
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS194528: GO:0060359 response to ammonium ion
|
|
GS201260: GO:0009894 regulation of catabolic process
|
|
GS166710: MP:0002163 abnormal gland morphology
|
|
GS167075: MP:0001924 infertility
|
|
GS203085: GO:0009146 purine nucleoside triphosphate catabolic process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS166675: MP:0005292 improved glucose tolerance
|
|
GS199634: GO:0005623 cell
|
|
GS199892: GO:0043271 negative regulation of ion transport
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS182622: GO:1901069 guanosine-containing compound catabolic process
|
|
GS189900: GO:0009119 ribonucleoside metabolic process
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS196933: GO:0065009 regulation of molecular function
|
|
GS86584: Table S8: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT OF DELTACJUN [DRG]
provisional
|
|
GS191115: GO:0051345 positive regulation of hydrolase activity
|
|
GS183053: GO:0019001 guanyl nucleotide binding
|
|
GS206620: GO:0050790 regulation of catalytic activity
|
|
GS169915: MP:0005560 decreased circulating glucose level
|
|
GS170693: MP:0004215 abnormal myocardial fiber physiology
|
|
GS198511: GO:0006163 purine nucleotide metabolic process
|
|
GS196898: GO:0009203 ribonucleoside triphosphate catabolic process
|
|
GS206215: GO:0042454 ribonucleoside catabolic process
|
|
GS202799: GO:0051049 regulation of transport
|
|
GS209452: GO:0006810 transport
|
|
GS129101: bone mineral density 39 (Bmd39 Published QTL Chr 8)
|
|
GS207385: GO:0009154 purine ribonucleotide catabolic process
|
|
GS184065: GO:0043085 positive regulation of catalytic activity
|
|
GS168666: MP:0003484 abnormal channel response
|
|
GS213073: Genes with suggestive difference in (PB6F1) vs (B6PF1 + B6 + PWD) comparison
|
|
GS135780: exercise endurance QTL 2 (Eeq2, Published QTL Chr 8)
|
|
GS165260: MP:0001392 abnormal locomotor behavior
|
|
GS185499: GO:0007626 locomotory behavior
|
|
GS191407: GO:0051926 negative regulation of calcium ion transport
|
|
GS187770: GO:1901565 organonitrogen compound catabolic process
|
|
GS195559: GO:0051336 regulation of hydrolase activity
|
|
GS187786: GO:0043547 positive regulation of GTPase activity
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS179211: GO:0007154 cell communication
|
|
GS192265: GO:0007165 signal transduction
|
|
GS180152: GO:0065007 biological regulation
|
|
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS165397: MP:0001265 decreased body size
|
|
GS185366: GO:0044248 cellular catabolic process
|
|
GS206785: GO:0009118 regulation of nucleoside metabolic process
|
|
GS183092: GO:0043271 negative regulation of ion transport
|
|
GS168097: MP:0009165 abnormal endocrine pancreas morphology
|
|
GS205180: GO:0005525 GTP binding
|
|
GS209568: GO:0048666 neuron development
|
|
GS186063: GO:0030811 regulation of nucleotide catabolic process
|
|
GS165255: MP:0001394 circling
|
|
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS166599: MP:0005333 decreased heart rate
|
|
GS127927: Hypothalamus - Allen Mouse Brain Atlas
|
|
GS186633: GO:0044093 positive regulation of molecular function
|
|
GS195665: GO:0017111 nucleoside-triphosphatase activity
|
|
GS136755: susceptibility to Salmonella typhimurium antigens 6 (Ssta6, Published QTL Chr 8)
|
|
GS200446: GO:0017076 purine nucleotide binding
|
|
GS206639: GO:0031821 G-protein coupled serotonin receptor binding
|
|
GS189901: GO:0009118 regulation of nucleoside metabolic process
|
|
GS854: Sey_Pax6_Int_No_Change_Lin_dec
|
|
GS184983: GO:0032550 purine ribonucleoside binding
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS209960: GO:0003008 system process
|
|
GS186235: GO:0009141 nucleoside triphosphate metabolic process
|
|
GS168958: MP:0003492 abnormal involuntary movement
|
|
GS192174: GO:0000166 nucleotide binding
|
|
GS191973: GO:0046700 heterocycle catabolic process
|
|
GS209614: GO:0055086 nucleobase-containing small molecule metabolic process
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS191268: GO:0010033 response to organic substance
|
|
GS208332: GO:0051924 regulation of calcium ion transport
|
|
GS87088: Table S8: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT OF DELTACJUN [DRG]
provisional
|
|
GS179414: GO:0031628 opioid receptor binding
|
|
GS26282: Whole Brain Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold in Females & Males BXD
|
|
GS180166: GO:0008152 metabolic process
|
|
GS203083: GO:0009144 purine nucleoside triphosphate metabolic process
|
|
GS203886: GO:1901265 nucleoside phosphate binding
|
|
GS86636: Table S6: GENES UPREGULATED AFTER 8 WEEKS DELTAFOSB VS.CONTROLS AND THE EFFECT AT 1, 2 AND 4 WEEKS [DRG]
provisional
|
|
GS164724: MP:0001516 abnormal motor coordination/ balance
|
|
GS192509: GO:0006810 transport
|
|
GS136059: Immunoregulatory 1 (Im1, Published QTL Chr 8)
|
|
GS189844: GO:0009261 ribonucleotide catabolic process
|
|
GS84206: METH responses for body temperature (Published QTL, Chr 8)
|
|
GS184978: GO:0032555 purine ribonucleotide binding
|
|
GS127936: Striatum ventral region - Allen Mouse Brain Atlas
|
|
GS135613: circulating hormone level QTL 5 (Chlq5, Published QTL Chr 8)
|
|
GS194476: GO:0019897 extrinsic to plasma membrane
|
|
GS177766: GO:1901135 carbohydrate derivative metabolic process
|
|
GS190714: GO:0016020 membrane
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS209450: GO:0006812 cation transport
|
|
GS191552: GO:0042995 cell projection
|
|
GS206784: GO:0009119 ribonucleoside metabolic process
|
|
GS188323: GO:0005525 GTP binding
|
|
GS180034: GO:0032502 developmental process
|
|
GS193193: GO:0016462 pyrophosphatase activity
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS180155: GO:0065009 regulation of molecular function
|
|
GS202370: GO:0006979 response to oxidative stress
|
|
GS187166: GO:0044708 single-organism behavior
|
|
GS168174: MP:0001919 abnormal reproductive system physiology
|
|
GS199495: GO:0051174 regulation of phosphorus metabolic process
|
|
GS199896: GO:0043278 response to morphine
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS198263: GO:0005488 binding
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS206355: GO:0023052 signaling
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS177765: GO:1901136 carbohydrate derivative catabolic process
|
|
GS195151: GO:0019637 organophosphate metabolic process
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS179139: GO:0008016 regulation of heart contraction
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS187833: GO:0060047 heart contraction
|
|
GS136512: prion incubation time 3 (Pitm3, Published QTL Chr 8)
|
|
GS205557: GO:0003012 muscle system process
|
|
GS135717: despair 1 (Desp1, Published QTL Chr 8)
|
|
GS124010: bismuth tripotassium dicitrate interacting genes (MeSH:C002791) in CTD
|
|
GS135844: femoral cross-sectional area 2 (Fcsa2, Published QTL Chr 8)
|
|
GS164301: MP:0005418 abnormal circulating hormone level
|
|
GS168995: MP:0009642 abnormal blood homeostasis
|
|
GS203080: GO:0009141 nucleoside triphosphate metabolic process
|
|
GS193952: GO:0042542 response to hydrogen peroxide
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS187769: GO:1901564 organonitrogen compound metabolic process
|
|
GS206780: GO:0009117 nucleotide metabolic process
|
|
GS192106: GO:0043087 regulation of GTPase activity
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS195176: GO:0005102 receptor binding
|
|
GS136355: novelty/stress induced locomotor activation 6 (Nsila6, Published QTL Chr 8)
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS206059: GO:0010959 regulation of metal ion transport
|
|
GS192507: GO:0006812 cation transport
|
|
GS185985: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS177307: GO:0051429 corticotropin-releasing hormone receptor binding
|
|
GS200192: GO:0005834 heterotrimeric G-protein complex
|
|
GS189855: GO:0043168 anion binding
|
|
GS136045: insulin dependent diabetes susceptibility 22 (Idd22, Published QTL Chr 8)
|
|
GS166257: MP:0005291 abnormal glucose tolerance
|
|
GS190997: GO:0044281 small molecule metabolic process
|